Salbutamol inhibits trypsin-mediated production of CXCL8 by keratinocytes

Cytokine

Volumn 36, Issue 1-2, 2006, Pages 29-34

  Wettey, Frank R ^a   Xue, Luzheng ^a   Pettipher, Roy ^a  

^a Oxagen Ltd   (United Kingdom)

Author keywords

2 agonist; Chemokines; Keratinocytes; Protease activated receptor 2

Indexed keywords

2',5' DIDEOXYADENOSINE; ADENYLATE CYCLASE; ADENYLATE CYCLASE INHIBITOR; BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CYCLIC AMP; FORSKOLIN; INTERLEUKIN 8; PHOSPHODIESTERASE IV INHIBITOR; ROLIPRAM; SALBUTAMOL; SOTALOL; TRYPSIN;

ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; IC 50; KERATINOCYTE; PRIORITY JOURNAL;

ADENYLATE CYCLASE; ALBUTEROL; CELLS, CULTURED; CYCLIC AMP; DIDEOXYADENOSINE; FORSKOLIN; HUMANS; INTERLEUKIN-8; KERATINOCYTES; ROLIPRAM; TRYPSIN;

EID: 33845977394     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2006.10.008     Document Type: Article

References (40)

1. Fraki J.E., Schechter N.M., and Lazarus G.S. Human skin proteinases as inflammatory mediators. Br J Dermatol 109 Suppl. 25 (1983) 72-76
2. Bos J.D., de Rie M.A., Teunissen M.B., and Piskin G. Psoriasis: dysregulation of innate immunity. Br J Dermatol 152 (2005) 1098-1107
3. Nickoloff B.J., Mitra R.S., Varani J., Dixit V.M., and Polverini P.J. Aberrant production of interleukin-8 and thrombospondin-1 by psoriatic keratinocytes mediates angiogenesis. Am J Pathol 144 (1994) 820-828
4. Lebwohl M. Psoriasis. Lancet 361 (2003) 1197-1204
5. Sticherling M., Bornscheuer E., Schroder J.M., and Christophers E. Localization of neutrophil-activating peptide-1/interleukin-8-immunoreactivity in normal and psoriatic skin. J Invest Dermatol 96 (1991) 26-30
6. Takematsu H., and Tagami H. Quantification of chemotactic peptides (C5a anaphylatoxin and IL-8) in psoriatic lesional skin. Arch Dermatol 129 (1993) 74-80
7. Larsen C.G., Anderson A.O., Appella E., Oppenheim J.J., and Matsushima K. The neutrophil-activating protein (NAP-1) is also chemotactic for T lymphocytes. Science 243 (1989) 1464-1466
8. Barker J.N., Jones M.L., Mitra R.S., Crockett-Torabe E., Fantone J.C., Kunkel S.L., et al. Modulation of keratinocyte-derived interleukin-8 which is chemotactic for neutrophils and T lymphocytes. Am J Pathol 139 (1991) 869-876
9. Koch A.E., Polverini P.J., Kunkel S.L., Harlow L.A., DiPietro L.A., Elner V.M., et al. Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science 258 (1992) 1798-1801
10. Anttila H.S., Reitamo S., Erkko P., Ceska M., Moser B., and Baggiolini M. Interleukin-8 immunoreactivity in the skin of healthy subjects and patients with palmoplantar pustulosis and psoriasis. J Invest Dermatol 98 (1992) 96-101
11. Kulke R., Bornscheuer E., Schluter C., Bartels J., Rowert J., Sticherling M., et al. The CXC receptor 2 is overexpressed in psoriatic epidermis. J Invest Dermatol 110 (1998) 90-94
12. Lemster B.H., Carroll P.B., Rilo H.R., Johnson N., Nikaein A., and Thomson A.W. IL-8/IL-8 receptor expression in psoriasis and the response to systemic tacrolimus (FK506) therapy. Clin Exp Immunol 99 (1995) 148-154
13. Michel G., Auer H., Kemeny L., Bocking A., and Ruzicka T. Antioncogene P53 and mitogenic cytokine interleukin-8 aberrantly expressed in psoriatic skin are inversely regulated by the antipsoriatic drug tacrolimus (FK506). Biochem Pharmacol 51 (1996) 1315-1320
14. Braun R.K., Franchini M., Erard F., Rihs S., De Vries I.J., Blaser K., et al. Human peripheral blood eosinophils produce and release interleukin-8 on stimulation with calcium ionophore. Eur J Immunol 23 (1993) 956-960
15. Saito S., Kasahara T., Sakakura S., Enomoto M., Umekage H., Harada N., et al. Interleukin-8 production by CD16-CD56 bright natural killer cells in the human early pregnancy deciduas. Biochem Biophys Res Commun 200 (1994) 378-383
16. Jeannin P., Delneste Y., Gosset P., Molet S., Lassalle P., Hamid Q., et al. Histamine induces interleukin-8 secretion by endothelial cells. Blood 84 (1994) 2229-2233
17. Ansel J., Perry P., Brown J., Damm D., Phan T., Hart C., et al. Cytokine modulation of keratinocyte cytokines. J Invest Dermatol 94 (1990) 101S-107S
18. Nickoloff B.J., Karabin G.D., Barker J.N., Griffiths C.E., Sarma V., Mitra R.S., et al. Cellular localization of interleukin-8 and its inducer, tumor necrosis factor-alpha in psoriasis. Am J Pathol 138 (1991) 129-140
19. Wilmer J.L., and Luster M.I. Chemical induction of interleukin-8, a proinflammatory chemokine, in human epidermal keratinocyte cultures and its relation to cytogenetic toxicity. Cell Biol Toxicol 11 (1995) 37-50
20. Pernet I., Sagot V., Schmitt D., and Viac J. UVA1 and UVB radiation but not PGE2 stimulate IL-8 release in normal human keratinocytes. Arch Dermatol Res 291 (1999) 527-529
21. Hou L., Kapas S., Cruchley A.T., Macey M.G., Harriott P., Chinni C., et al. Immunolocalization of protease-activated receptor-2 in skin: receptor activation stimulates interleukin-8 secretion by keratinocytes in vitro. Immunology 94 (1998) 356-362
22. Santulli R.J., Derian C.K., Darrow A.L., Tomko K.A., Eckardt A.J., Seiberg M., et al. Evidence for the presence of a protease-activated receptor distinct from the thrombin receptor in human keratinocytes. Proc Natl Acad Sci USA 92 (1995) 9151-9155
23. Steinhoff M., Corvera C.U., Thoma M.S., Kong W., McAlpine B.E., Caughey G.H., et al. Proteinase-activated receptor-2 in human skin: tissue distribution and activation of keratinocytes by mast cell tryptase. Exp Dermatol 8 (1999) 282-294
24. Seeliger S., Derian C.K., Vergnolle N., Bunnett N.W., Nawroth R., Schmelz M., et al. Proinflammatory role of proteinase-activated receptor-2 in humans and mice during cutaneous inflammation in vivo. FASEB J 17 (2003) 1871-1885
25. Déry O., Corvera C.U., Steinhoff M., and Bunnett N.W. Proteinase-activated receptors: novel mechanisms of signaling by serine proteases. Am J Physiol 274 (1998) C1429-C1452
26. Pestelli E., Caproni M., Giomi B., Volpi W., Spallanzani A., Cardinali C., et al. Cetirizine reduces the number of tryptase-positive mast cells in psoriatic patients: a double-blind controlled study. Int J Tissue React 23 (2001) 97-103
27. Steinkraus V., Steinfath M., Korner C., and Mensing H. Binding of beta-adrenergic receptors in human skin. J Invest Dermatol 98 (1992) 475-480
28. Schallreuter K.U., Wood J.M., Pittelkow M.R., Swanson N.N., and Steinkraus V. Increased in vitro expression of beta 2-adrenoceptors in differentiating lesional keratinocytes of vitiligo patients. Arch Dermatol Res 285 (1993) 216-220
29. Steinkraus V., Mak J.C., Pichlmeier U., Mensing H., Ring J., and Barnes P.J. Autoradiographic mapping of beta-adrenoceptors in human skin. Arch Dermatol Res 288 (1996) 549-553
30. Chen J., Hoffman B.B., and Isseroff R.R. Beta-adrenergic receptor activation inhibits keratinocyte migration via a cyclic adenosine monophosphate-independent mechanism. J Invest Dermatol 119 (2002) 1261-1268
31. Pullar C.E., Chen J., and Isseroff R.R. PP2A activation by beta2-adrenergic receptor agonists: novel regulatory mechanism of keratinocyte migration. J Biol Chem 278 (2003) 22555-22562
32. Severn A., Rapson N.T., Hunter C.A., and Liew F.Y. Regulation of tumor necrosis factor production by adrenaline and beta-adrenergic agonists. J Immunol 148 (1992) 3441-3445
33. Sekut L., Champion B.R., Page K., Menius Jr. J.A., and Connolly K.M. Anti-inflammatory activity of salmeterol: down-regulation of cytokine production. Clin Exp Immunol 99 (1995) 461-466
34. Au B.T., Teixeira M.M., Collins P.D., and Williams T.J. Effect of PDE4 inhibitors on zymosan-induced IL-8 release from human neutrophils: synergism with prostanoids and salbutamol. Br J Pharmacol 123 (1998) 1260-1266
35. Banner K.H., Moriggi E., Da Ros B., Schioppacassi G., Semeraro C., and Page C.P. The effect of selective phosphodiesterase 3 and 4 isoenzyme inhibitors and established anti-asthma drugs on inflammatory cell activation. Br J Pharmacol 119 (1996) 1255-1261
36. Li C.Y., Tsai C.S., Hsu P.C., Wu C.T., Wong C.S., and Ho S.T. Dobutamine modulates lipopolysaccharide-induced macrophage inflammatory protein-1alpha and interleukin-8 production in human monocytes. Anesth Analg 97 (2003) 210-215
37. Panina-Bordignon P., Mazzeo D., Lucia P.D., D'Ambrosio D., Lang R., Fabbri L., et al. Beta2-agonists prevent Th1 development by selective inhibition of interleukin 12. J Clin Invest 100 (1997) 1513-1519
38. Redondo P., Garcia-Foncillas J., Espana A., Cuevillas F., and Quintanilla E. Differential modulation of IL-8 and TNF-alpha expression in human keratinocytes by buflomedil chlorhydrate and pentoxifylline. Exp Dermatol 6 (1997) 186-194
39. Grandjean-Laquerriere A., Le Naour R., Gangloff S.C., and Guenounou M. Contribution of protein kinase A and protein kinase C pathways in ultraviolet B-induced IL-8 expression by human keratinocytes. Cytokine 29 (2005) 197-207
40. Seldon P.M., Meja K.K., and Giembycz M.A. Rolipram, salbutamol and prostaglandin E2 suppress TNFα release from human monocytes. Pulm Pharmacol Ther 18 (2005) 277-284